Ourania Tatsis Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Jul 23, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
53.6K sh
45,321 → 53,572
Equity Change
+18.2%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Ourania Tatsis CIK 0001789815 |
EVP
|
Ourania Tatsis at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$6,513,286
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-07-07 | Sell | -$787,485 | View |
| 2026-02-26 | Sell | -$126,451 | View |
| 2026-02-19 | Sell | -$472,395 | View |
| 2026-02-18 | Sell | -$749,985 | View |
| 2026-02-12 | Sell | -$214,560 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-07-21 | A - Award/Grant | 8,251 A | $0.00 | — | 53,572 | Direct |
Footnotes (1)
- F1
- Restricted stock unit award that vests on 03/31/2030. Show more
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000875320-26-000253
API docs
View Original SEC Filing